The objective of this study is to investigate possible factors that will affect the choice of androgen deprivation therapy in prostate cancer patients. This is a cross-sectional study performed in Prince of Wales Hospital in Hong Kong. One hundred patients will be recruited for this study.
Conditions: Prostate Cancer
Eligibility Criteria
Inclusion Criteria
- Prostate cancer only happens in male patients
- Patients who are currently receiving at least one dose of LHRH agonist or antagonist, as androgen deprivation therapy
- Patients who are willing to consent and participate in this study
Exclusion Criteria
- Patients who received bilateral orchidectomy as androgen deprivation therapy
- Patients who, in the opinion of investigators, are not able to comprehend about the study questions
Eligibility criteria are kept as the original English records from ClinicalTrials.gov; actual eligibility is determined by the research team's formal assessment and the informed consent form. Source: ClinicalTrials.gov, updated automatically every two weeks. Last synced: 2026年11月5日.